0001179110-17-009132.txt : 20170615
0001179110-17-009132.hdr.sgml : 20170615
20170615215103
ACCESSION NUMBER: 0001179110-17-009132
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170614
FILED AS OF DATE: 20170615
DATE AS OF CHANGE: 20170615
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc.
CENTRAL INDEX KEY: 0001651561
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389]
IRS NUMBER: 465726437
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
BUSINESS PHONE: 866-648-2767
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Knowlton Orsula V
CENTRAL INDEX KEY: 0001685832
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37888
FILM NUMBER: 17914691
MAIL ADDRESS:
STREET 1: 228 STRAWBRIDGE DRIVE
STREET 2: SUITE 100
CITY: MOORESTOWN
STATE: NJ
ZIP: 08057
4
1
edgar.xml
FORM 4 -
X0306
4
2017-06-14
0
0001651561
Tabula Rasa HealthCare, Inc.
TRHC
0001685832
Knowlton Orsula V
228 STRAWBRIDGE DRIVE
SUITE 100
MOORESTOWN
NJ
08057
1
1
1
0
President
Common Stock
2017-06-14
4
S
0
8000
14.02
D
911407
D
Common Stock
914072
I
Held by spouse.
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 4, 2017.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $13.72 to $14.41, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in footnote (2) to this Form 4.
Dr. Knowlton received a restricted stock award of 267,268 shares of the Company's common stock on September 28, 2016. All such shares of common stock were scheduled to vest on May 31, 2017. Notwithstanding the foregoing, on June 12, 2017, the Company entered into an amendment to the restricted stock award with Dr. Knowlton and, pursuant thereto, all shares underlying such restricted stock award will now vest in full on May 31, 2018.
Calvin Knowlton received a restricted stock award of 337,307 shares of the Company's common stock on September 28, 2016. All such shares of common stock were scheduled to vest on May 31, 2017. Notwithstanding the foregoing, on June 12, 2017, the Company entered into an amendment to the restricted stock award with Calvin Knowlton and, pursuant thereto, all shares underlying such restricted stock award will now vest in full on May 31, 2018.
/s/ Brian W. Adams, by Power of Attorney previously filed
2017-06-15